Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 20.45B 3.02B 2.64B 2.44B 2.28B 4.28B 285B 4.31B 29B 11.28B 140B 11.34B 11.09B 487B P/E 2026 *
15.4x
P/E 2027 * 12.9x
Enterprise Value 18.19B 2.69B 2.35B 2.17B 2.03B 3.8B 254B 3.83B 25.8B 10.04B 125B 10.09B 9.87B 434B EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.81x
Free-Float
46.34%
Yield 2026 *
2.93%
Yield 2027 * 3.68%
1 day-2.84%
1 week-5.00%
Current month-2.70%
1 month-4.80%
3 months-3.25%
6 months-10.11%
Current year-9.16%
1 week 13.38
Extreme 13.38
14.57
1 month 13.38
Extreme 13.38
14.6
Current year 13.38
Extreme 13.38
15.49
1 year 13.38
Extreme 13.38
17.69
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 2024-05-07
Director of Finance/CFO 49 2018-07-08
Chief Investment Officer 45 2025-04-30
Director TitleAgeSince
Director/Board Member 58 2024-03-31
Director/Board Member 62 2007-08-16
Director/Board Member 72 2021-06-01
Change 5-day change 1-year change 3-year change Capi.($)
-2.84%-5.00%-11.68%-3.05% 3.11B
+0.47%-3.83%-11.58%-7.05% 12.77B
+0.21%-5.61%-34.57%-56.61% 4.76B
-0.83%-10.26%-13.37%-4.03% 4.34B
-0.13%-1.33%+15.71%-15.38% 3.8B
+0.20%-4.20%+8.20%-41.30% 3.71B
-0.66%-5.05%-5.99%-8.95% 3.53B
-1.11%-0.72%-5.15%-25.12% 2.38B
-0.94%-4.32%-12.63%+31.12% 1.67B
-1.17%-5.42%-13.44%-16.36% 1.64B
Average -0.68%-4.77%-8.45%-14.67% 4.17B
Weighted average by Cap. -0.33%-4.42%-9.43%-15.93%

Financials

2026 *2027 *
Net sales 9B 1.33B 1.16B 1.07B 1B 1.88B 125B 1.89B 12.75B 4.96B 61.7B 4.99B 4.88B 214B 9.87B 1.46B 1.27B 1.18B 1.1B 2.06B 138B 2.08B 14B 5.45B 67.7B 5.47B 5.35B 235B
Net income 1.33B 196M 171M 158M 148M 277M 18.51B 279M 1.88B 732M 9.1B 736M 720M 31.62B 1.59B 234M 205M 189M 177M 332M 22.13B 334M 2.25B 875M 10.88B 879M 860M 37.8B
Net Debt -2.26B -333M -291M -269M -251M -472M -31.5B -475M -3.2B -1.25B -15.49B -1.25B -1.22B -53.8B -2.58B -380M -332M -307M -287M -538M -35.93B -542M -3.65B -1.42B -17.66B -1.43B -1.4B -61.36B
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
26-06-21 13.69 ¥ -2.84% 17,387,070
26-06-18 14.09 ¥ -0.07% 6,295,319
26-06-17 14.10 ¥ -0.77% 5,621,452
26-06-16 14.21 ¥ -2.20% 7,621,471
26-06-15 14.53 ¥ +0.83% 11,681,030
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.69CNY
Average target price
17.18CNY
Spread / Average Target
+25.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600535 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!